Special Issue "Metabolites in Diatoms"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 31 December 2014

Special Issue Editor

Guest Editor
Dr. Véronique Martin-Jézéquel
IUML, FR 3473 CNRS, University of Nantes, EA 2160, 2 rue de la Houssinière, F-44322, Nantes, France
Website: http://www.univ-nantes.fr/martin-jezequel-v/0/fiche___annuaireksup/
E-Mail: Veronique.Martin-Jezequel@univ-nantes.fr
Phone: +33 2 51 12 56 66
Interests: diatoms; carbon and nitrogen metabolism; silicium; physiology; biochemistry; phytoplankton and microphytobenthos ecology

Special Issue Information

Dear Colleagues,

Diatoms constitute one of the major lineages of photosynthetic eukaryotes, and appear as major contributor in aquatic systems with more of 100,000 species. Moreover, they have a specific chemistry involved during their cellular growth in relation with their silica shell. Because of their success in many different habitats, open ocean, coastal waters or pools, from hypersaline to fresh waters, diatoms have developed physiological capacities within a wide range of growth conditions. Their biochemistry has been first studied with regard to their ecological situation, and their natural compounds first related to nutritional value and use in aquaculture. More recently, the role of diatoms as source of secondary metabolites with biological activity, such as the toxic domoïc acid, has been explored. Progress on identification of all theses components was recently facilitated due to the use of new techniques, including molecular genetic tools and different chemical approach. However, many aspects of diatom’s metabolism and production of natural compounds are still unknown. In this special issue, we want to explore all topics in physiological regulations and production of metabolites in relation with diatom’s growth. This issue will cover many aspects of diatom’s biochemistry, biosynthesis and diversity of metabolites, ecological role as well as prospects in biotechnological and biomedical application.

As guest editor, I invite you to contribute to the special issue on “Metabolites in Diatoms”.
Original research reports and reviews will be published online in Marine Drugs.

Dr. Véronique Martin-Jézéquel
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • diatom
  • secondary metabolite
  • biosynthesis
  • metabolic fingerprint
  • pigment
  • toxin (domoic acid)
  • oxylipin
  • polyunsaturated aldehyde (PUA)
  • polyunsaturated fatty acid (PUFA)
  • chemical ecology
  • bioactive molecule
  • apoptosis
  • biotechnology

Published Papers (12 papers)

Mar. Drugs 2014, 12(7), 4165-4187; doi:10.3390/md12074165
Received: 18 January 2014; in revised form: 4 June 2014 / Accepted: 30 June 2014 / Published: 14 July 2014
Show/Hide Abstract | PDF Full-text (854 KB) | HTML Full-text | XML Full-text
abstract graphic

Mar. Drugs 2014, 12(6), 3587-3607; doi:10.3390/md12063587
Received: 5 March 2014; in revised form: 4 April 2014 / Accepted: 17 April 2014 / Published: 11 June 2014
Show/Hide Abstract | PDF Full-text (660 KB) | HTML Full-text | XML Full-text

Mar. Drugs 2014, 12(6), 3161-3189; doi:10.3390/md12063161
Received: 19 March 2014; in revised form: 29 April 2014 / Accepted: 29 April 2014 / Published: 28 May 2014
Show/Hide Abstract | PDF Full-text (3074 KB) | HTML Full-text | XML Full-text

Mar. Drugs 2014, 12(3), 1438-1459; doi:10.3390/md12031438
Received: 19 November 2013; in revised form: 14 February 2014 / Accepted: 18 February 2014 / Published: 13 March 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (2176 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

Mar. Drugs 2014, 12(3), 1317-1334; doi:10.3390/md12031317
Received: 12 November 2013; in revised form: 13 February 2014 / Accepted: 17 February 2014 / Published: 7 March 2014
Show/Hide Abstract | PDF Full-text (1185 KB) | HTML Full-text | XML Full-text | Supplementary Files

Mar. Drugs 2014, 12(2), 682-699; doi:10.3390/md12020682
Received: 19 November 2013; in revised form: 10 January 2014 / Accepted: 15 January 2014 / Published: 27 January 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (859 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

Mar. Drugs 2014, 12(1), 547-567; doi:10.3390/md12010547
Received: 26 November 2013; in revised form: 9 January 2014 / Accepted: 15 January 2014 / Published: 22 January 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (1700 KB) | HTML Full-text | XML Full-text

Mar. Drugs 2014, 12(1), 368-384; doi:10.3390/md12010368
Received: 18 November 2013; in revised form: 20 December 2013 / Accepted: 23 December 2013 / Published: 17 January 2014
Show/Hide Abstract | PDF Full-text (1172 KB) | HTML Full-text | XML Full-text | Supplementary Files

Mar. Drugs 2014, 12(1), 352-367; doi:10.3390/md12010352
Received: 5 November 2013; in revised form: 16 December 2013 / Accepted: 23 December 2013 / Published: 17 January 2014
Show/Hide Abstract | PDF Full-text (497 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

Mar. Drugs 2014, 12(1), 153-166; doi:10.3390/md12010153
Received: 18 October 2013; in revised form: 10 December 2013 / Accepted: 12 December 2013 / Published: 7 January 2014
Show/Hide Abstract | Cited by 1 | PDF Full-text (1039 KB) | HTML Full-text | XML Full-text

Mar. Drugs 2013, 11(12), 5008-5023; doi:10.3390/md11125008
Received: 18 October 2013; in revised form: 18 November 2013 / Accepted: 20 November 2013 / Published: 11 December 2013
Show/Hide Abstract | PDF Full-text (377 KB) | HTML Full-text | XML Full-text | Supplementary Files

Mar. Drugs 2013, 11(11), 4232-4245; doi:10.3390/md11114232
Received: 12 August 2013; in revised form: 17 October 2013 / Accepted: 17 October 2013 / Published: 30 October 2013
Show/Hide Abstract | PDF Full-text (578 KB) | HTML Full-text | XML Full-text

Last update: 9 May 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert